Pfizer
PFE
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Business Wire • 7 hours ago • PFE
HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors
The Motley Fool • 1 day ago • PFE
Do These 3 Healthcare Stocks Need a Checkup?
Seeking Alpha • 2 days ago • PFE
Pfizer: The Market Is Still Wrong About It
Zacks Investment Research • 2 days ago • PFE
Pfizer (PFE) Up 3.9% Since Last Earnings Report: Can It Continue?
24/7 Wall Street • 3 days ago • PFE
Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (December 2025)
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.